ZFIN ChEBI: glycerophosphoglycerols

Relationships

is a type of: glycerophospholipid

glycerophospholipid Show first 5 Terms
has subtype: (R,R)-2-oleoylglycero-1-phospho-1'-glycerol (S,S)-2-oleoylglycero-1-phospho-1'-glycerol (S,S)-3-oleoylglycero-1-phospho-1'-glycerol 1,2-dioleoyl-sn-glycero-3-phospho-1'-(3'-oleoyl)-sn-glycerol 1-(6-[3]-ladderane-hexanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycero-3-phospho-(1'-sn-glycerol) ... Show All 119 Terms

(R,R)-2-oleoylglycero-1-phospho-1'-glycerol (S,S)-2-oleoylglycero-1-phospho-1'-glycerol (S,S)-3-oleoylglycero-1-phospho-1'-glycerol 1,2-dioleoyl-sn-glycero-3-phospho-1'-(3'-oleoyl)-sn-glycerol 1-(6-[3]-ladderane-hexanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycero-3-phospho-(1'-sn-glycerol) 1-(6-[5]-ladderane-hexanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycero-3-phospho-(1'-sn-glycerol) 1-(8-(5)-ladderane-octanoyl)-2-(8-(3)-ladderane-octanyl)-sn-glycero-3-phospho-(1'-sn-glycerol) 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycero-3-phospho-(1'-sn-glycerol) 1-(8-[3]-ladderane-octanyl)-2-(8-[3]-ladderane-octanyl)-sn-glycero-3-phospho-(1'-sn-glycerol) 1-(8-[5]-ladderane-octanyl)-2-(8-[3]-ladderane-octanyl)-sn-glycero-3-phospho-(1'-sn-glycerol) 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoglycerol 1-(alk-1-enyl)-2-acylglycero-3-phosphoglycerol 1-(Z-alk-1-enyl)-sn-glycero-3-phosphoglycerol 1-acyl-sn-glycero-3-phosphoglycerol 1-alkyl-2-acylglycero-3-phosphoglycerol 1-alkyl-sn-glycero-3-phosphoglycerol 1-Stearoylglycerophosphoglycerol 1-tetradecanyl-2-(8-[3]-ladderane-octanyl)-sn-glycero-3-phospho-(1'-sn-glycerol) 2-acyl-sn-glycero-3-phosphoglycerol alkyl,acyl-sn-glycero-3-phosphoglycerol bacilysocin glycerophosphoglycerol LBPA(16:1(9Z)/18:1(9Z)) LPG 16:2 LPG 17:1 LPG 19:1 LPG 20:2 LPG 20:5 LPG 22:4 LPG(22:5) lysophosphatidylglycerol Nis(monooleoylglycero)phosphate (s,r isomer) PG(12:0/0:0) PG(13:0/0:0) PG(14:1(9Z)/0:0) PG(15:1(9Z)/0:0) PG(17:0/0:0) PG(17:1(9Z)/0:0) PG(17:2(9Z,12Z)/0:0) PG(18:3(6Z,9Z,12Z)/0:0) PG(18:3(9Z,12Z,15Z)/0:0) PG(19:0/0:0) PG(19:1(9Z)/0:0) PG(20:1(11Z)/0:0) PG(20:2(11Z,14Z)/0:0) PG(20:3(8Z,11Z,14Z)/0:0) PG(20:4(5Z,8Z,11Z,14Z)/0:0) PG(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) PG(21:0/0:0) PG(22:0/0:0) PG(22:1(11Z)/0:0) PG(22:2(13Z,16Z)/0:0) PG(22:4(7Z,10Z,13Z,16Z)/0:0) PG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) PG(O-16:0/0:0) PG(O-16:0/14:0) PG(O-16:0/14:1(9Z)) PG(O-16:0/16:1(9Z)) PG(O-16:0/17:2(9Z,12Z)) PG(O-16:0/18:0) PG(O-16:0/18:1(9Z)) PG(O-16:0/18:3(9Z,12Z,15Z)) PG(O-16:0/19:0) PG(O-16:0/19:1(9Z)) PG(O-16:0/20:3(8Z,11Z,14Z)) PG(O-16:0/20:4(5Z,8Z,11Z,14Z)) PG(O-16:0/21:0) PG(O-16:0/22:4(7Z,10Z,13Z,16Z)) PG(O-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) PG(O-16:0/O-16:0) PG(O-18:0/0:0) PG(O-18:0/14:0) PG(O-18:0/16:0) PG(O-18:0/16:1(9Z)) PG(O-18:0/17:0) PG(O-18:0/18:0) PG(O-18:0/18:2(9Z,12Z)) PG(O-18:0/18:3(6Z,9Z,12Z)) PG(O-18:0/18:3(9Z,12Z,15Z)) PG(O-18:0/18:4(6Z,9Z,12Z,15Z)) PG(O-18:0/19:0) PG(O-18:0/19:1(9Z)) PG(O-18:0/20:2(11Z,14Z)) PG(O-18:0/20:4(5Z,8Z,11Z,14Z)) PG(O-18:0/22:1(11Z)) PG(O-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) PG(O-20:0/0:0) PG(O-20:0/14:0) PG(O-20:0/14:1(9Z)) PG(O-20:0/15:0) PG(O-20:0/17:0) PG(O-20:0/17:1(9Z)) PG(O-20:0/17:2(9Z,12Z)) PG(O-20:0/18:4(6Z,9Z,12Z,15Z)) PG(O-20:0/19:1(9Z)) PG(O-20:0/22:1(11Z)) PG(O-20:0/22:2(13Z,16Z)) PG(P-16:0/14:1(9Z)) PG(P-16:0/17:1(9Z)) PG(P-16:0/18:0) PG(P-16:0/20:2(11Z,14Z)) PG(P-16:0/20:3(8Z,11Z,14Z)) PG(P-16:0/20:4(5Z,8Z,11Z,14Z)) PG(P-16:0/20:5(5Z,8Z,11Z,14Z,17Z)) PG(P-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) PG(P-18:0/15:1(9Z)) PG(P-18:0/16:0) PG(P-18:0/18:1(9Z)) PG(P-18:0/18:3(6Z,9Z,12Z)) PG(P-18:0/19:0) PG(P-18:0/20:5(5Z,8Z,11Z,14Z,17Z)) PG(P-20:0/16:1(9Z)) PG(P-20:0/17:2(9Z,12Z)) PG(P-20:0/19:1(9Z)) PG(P-20:0/22:0) PG(P-20:0/22:2(13Z,16Z)) PG(P-20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) phosphatidylglycerol SLBPA(42:0) Show first 5 Terms

Phenotype

Phenotype resulting from glycerophosphoglycerols

Phenotype where environments contain glycerophosphoglycerols

Phenotype modified by environments containing glycerophosphoglycerols

Human Disease Model